The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of irinotecan plus s-1 (IRIS) with cetuximab (IRIS/Cet) as second-line treatment in patients with KRAS wild-type metastatic colorectal cancer (mCRC): HGCSG0902—Comparison of administration interval in cetuximab treatment.
 
Yoshito Komatsu
Honoraria - Bristol-Myers Squibb Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Speakers' Bureau - Bristol-Myers Squibb Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Bristol-Myers Squibb Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
 
Satoshi Yuki
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Taiho Pharmaceutical
 
Hiroshi Nakatsumi
No Relationships to Disclose
 
Ayumu Hosokawa
Research Funding - Daiichi Sankyo (Inst)
 
Michio Nakamura
No Relationships to Disclose
 
Osamu Muto
No Relationships to Disclose
 
Takashi Meguro
No Relationships to Disclose
 
Ichiro Iwanaga
No Relationships to Disclose
 
Kazuteru Hatanaka
No Relationships to Disclose
 
Yasushi Tsuji
Honoraria - Bristol-Myers Squibb Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
 
Atsushi Sato
Honoraria - Bristol-Myers Squibb; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Speakers' Bureau - Bristol-Myers Squibb Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Bristol-Myers Squibb Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
 
Kazunori Eto
No Relationships to Disclose
 
Kouichi Furukawa
No Relationships to Disclose
 
Manabu Onodera
No Relationships to Disclose
 
Miki Tateyama
No Relationships to Disclose
 
Yasuo Takahashi
No Relationships to Disclose
 
Masayoshi Dazai
No Relationships to Disclose
 
Sachio Yokoyama
No Relationships to Disclose
 
Takuya Honda
No Relationships to Disclose
 
Yuh Sakata
Honoraria - Bristol-Myers Squibb Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Speakers' Bureau - Bristol-Myers Squibb Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha